Moffitt logo
calledFromCancerPage=False - substr=
testProtocol=

Clinical Trials Search

Search Results:

Order By: 

Showing of 50

CLINICAL TRIAL 18994

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

Disease Site: Lip, Oral Cavity and Pharynx, Larynx, Head & Neck

View Trial Details

CLINICAL TRIAL 19473

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

Disease Site: Other Endocrine System, Head & Neck

View Trial Details

CLINICAL TRIAL 19570

A Phase II Trial of Pembrolizumab and Cabozantinib in Patients with RM SCCHN

Disease Site: Other Endocrine System, Head & Neck

View Trial Details

CLINICAL TRIAL 19748

Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial)

Disease Site: Lip, Oral Cavity and Pharynx, Other Skin, Head & Neck, Squamous Cell Carcinoma (SCC)

View Trial Details

CLINICAL TRIAL 19855

The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma(HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Disease Site: Lip, Oral Cavity and Pharynx, Larynx, Head & Neck, Squamous Cell Carcinoma (SCC)

View Trial Details

CLINICAL TRIAL 20114

A Single Arm Phase II Study of Cemiplimab-rwlc in Immunocompromised Patients with Unresectable Locally Recurrent and/or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Disease Site: Other Head & Neck, Other Skin, Skin, Squamous Cell Carcinoma (SCC)

View Trial Details

CLINICAL TRIAL 20144

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Squamous Cell Carcinoma (SCC)

View Trial Details

CLINICAL TRIAL 20485

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment

Disease Site: Any Site, Head & Neck, Larynx, Mouth, lip, nasal cavity, Throat

View Trial Details

CLINICAL TRIAL 20845

Health Insurance Literacy in Head and Neck Cancer Patients

Disease Site: Esophageal (Throat), Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Mouth, lip, nasal cavity, Pharynx

View Trial Details

CLINICAL TRIAL 21079

Head and Neck Cancer Pre-Surgery Education and Discharge Planning: Key Stakeholder Perceptions

Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx

View Trial Details
;